TipRanks
Go Ultimate55% OFF

Huw Jones Insider Profile

4 Followers

Huw Jones, Chief Executive Officer at Evgen Pharma, holds 10.74M shares in Evgen Pharma (Ticker: GB:TCF). Most recently, Huw Jones Bought 5,555,555 shares of Evgen Pharma on Aug 20, 2026 for an estimated value of 10.00K .

Huw Jones's Trading History

TCF
Evgen Pharma
Aug 20, 2026Chief Executive OfficerInformative Buy10.00K£18.26K
GB:TCF
Insider Shares: 10.74M (49.98%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 20, 2026Informative Buy£10.00K5,555,555£0.00-10.50%―
Feb 19, 2025Informative Buy£5.00K2,000,000£0.00-21.60%―
Apr 05, 2024Uninformative Buy£1.76K122,293£1.00――
Mar 20, 2024Informative Buy£30.00K3,000,000£1.00-76.90%―
Feb 02, 2021Informative Buy£5.00K62,500£8.00-53.30%―

You May Also Like

Huw Jones insider profile FAQ

What is the percentage of profitable transactions made by Huw Jones?
The percentage of profitable transactions made by Huw Jones is 0%.
What is the average return per transaction made by Huw Jones?
The average return per transaction made by Huw Jones is -40.50%.
What stocks does Huw Jones hold?
Huw Jones holds: GB:TCF stocks.
What was Huw Jones’s latest transaction?
Huw Jones’s latest transaction was an Informative Buy of 10.00K .
What was Huw Jones's most profitable transaction?
Huw Jones’s most profitable transaction was an Informative Buy of GB:TCF stock on August 20, 2026. The return on the trade was -10.50%.
What is Huw Jones's role in Evgen Pharma?
Huw Jones's role in Evgen Pharma is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.